Lilly Brings Full Value Of Cialis In-House With Purchase Of Partner ICOS

Lilly will acquire its joint venture partner ICOS for approximately $2.1 bil. to gain the full rights to the erectile dysfunction drug Cialis (tadalafil), which the two companies have partnered on since 1998